Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amblyoptica appears to have been a small Australian ophthalmic medical-device company focused on amblyopia, or lazy eye. Publicly discoverable information indicates it developed non-patching visual training and occlusion-based eyewear approaches intended to treat amblyopia, including patent filings assigned to Amblyoptica Holding Pty Ltd. The company seems to have operated from Queensland, Australia, with a very small team and limited public commercial footprint. Corporate registry and business-directory sources indicate the holding company was subject to proposed deregistration and is no longer active, and there is no clear evidence of a marketed product, broad financing history, or a current operating website. Overall, Amblyoptica looks like an early-stage, now-inactive medtech venture in pediatric eye care rather than a conventional biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amblyoptica.